Login

Indegene Ltd.

₹550.6

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Indegene Ltd.

₹550.6

₹550.6

17.7 (3.32%) - 8 Apr 2025 04:26 PM

About Company

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. It achieves this by combining over two decades of healthcare domain expertise and fit-for purpose technology. 

Market Cap. ₹12,787 Cr.
52 Week - High/Low ₹736/470
P/E Ratio 70.30
P/B Ratio 13.41
Enterprise Value ₹12,825 Cr.
ROE % 16.22
RSI Value 44.14
EMA 50 565.81
EMA 200 593.2
Net Profit 138 Cr.
Net Profit 3year growth 4.15 Cr.
Net Profit 3 year (back) 132 Cr.
Debt to Equity 0.0 %
EPS Growth TTM 43.29 %
Current Ratio 3.79 %
100 Day SMA 596 Rs.
200 Day SMA 608 Rs.
21 Day SMA 545 Rs.
50 Day SMA 566 Rs.
Book Value 40 Rs.
EV/EBITDA Ratio 48
QoQ EPS Growth 11 %
QoQ Operating Profit Growth 12 %
QoQ Sales Growth 2 %
Sales Latest Quarter 287 Cr.
YoY Sales Growth 10 %
Market Cap. ₹12,787 Cr.
52 Week - High/Low ₹736/470
P/E Ratio 32.32
P/B Ratio 8.95
Enterprise Value ₹13,031 Cr.
ROE % 27.56
RSI Value 44.14
EMA 50 565.81
EMA 200 593.2
Net Profit 337 Cr.
Net Profit 3year growth 4.47 Cr.
Net Profit 3 year (back) 149 Cr.
Debt to Equity 0.29 %
EPS Growth TTM 25.69 %
Current Ratio 2.93 %
100 Day SMA 596 Rs.
200 Day SMA 608 Rs.
21 Day SMA 545 Rs.
50 Day SMA 566 Rs.
Book Value 60 Rs.
EV/EBITDA Ratio 21
QoQ EPS Growth 20 %
QoQ Operating Profit Growth 5 %
QoQ Sales Growth 5 %
Sales Latest Quarter 720 Cr.
YoY Sales Growth 7 %
Add Parameters

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.